Scientech Research LLC Raises Holdings in Intuitive Surgical, Inc. $ISRG

Scientech Research LLC boosted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 105.1% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,238 shares of the medical equipment provider’s stock after purchasing an additional 2,684 shares during the quarter. Intuitive Surgical comprises 0.7% of Scientech Research LLC’s holdings, making the stock its 4th largest holding. Scientech Research LLC’s holdings in Intuitive Surgical were worth $2,594,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors also recently added to or reduced their stakes in the company. Castleark Management LLC boosted its position in Intuitive Surgical by 3.4% during the fourth quarter. Castleark Management LLC now owns 90,469 shares of the medical equipment provider’s stock valued at $47,221,000 after purchasing an additional 2,990 shares in the last quarter. Arlington Trust Co LLC boosted its position in Intuitive Surgical by 34.5% during the first quarter. Arlington Trust Co LLC now owns 745 shares of the medical equipment provider’s stock valued at $369,000 after purchasing an additional 191 shares in the last quarter. Aveo Capital Partners LLC boosted its position in Intuitive Surgical by 37.4% during the first quarter. Aveo Capital Partners LLC now owns 727 shares of the medical equipment provider’s stock valued at $390,000 after purchasing an additional 198 shares in the last quarter. Aaron Wealth Advisors LLC boosted its holdings in Intuitive Surgical by 3.2% in the first quarter. Aaron Wealth Advisors LLC now owns 2,509 shares of the medical equipment provider’s stock worth $1,243,000 after acquiring an additional 78 shares in the last quarter. Finally, Longbow Finance SA boosted its holdings in Intuitive Surgical by 132.0% in the first quarter. Longbow Finance SA now owns 19,699 shares of the medical equipment provider’s stock worth $9,756,000 after acquiring an additional 11,209 shares in the last quarter. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Up 2.7%

Shares of NASDAQ:ISRG opened at $466.86 on Friday. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $616.00. The stock has a market cap of $167.36 billion, a price-to-earnings ratio of 65.11, a PEG ratio of 4.89 and a beta of 1.61. The business has a 50-day moving average price of $494.00 and a 200-day moving average price of $512.73.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The firm had revenue of $2.44 billion during the quarter, compared to analysts’ expectations of $2.35 billion. During the same period last year, the business posted $1.78 earnings per share. The company’s revenue for the quarter was up 21.4% compared to the same quarter last year. As a group, equities analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several brokerages have weighed in on ISRG. BTIG Research raised their price target on Intuitive Surgical from $566.00 to $571.00 and gave the stock a “buy” rating in a report on Wednesday, July 23rd. Wall Street Zen raised Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Saturday, July 26th. Deutsche Bank Aktiengesellschaft reissued a “sell” rating on shares of Intuitive Surgical in a report on Friday, August 22nd. Wells Fargo & Company raised their price target on Intuitive Surgical from $559.00 to $599.00 and gave the stock an “overweight” rating in a report on Wednesday, July 23rd. Finally, Evercore ISI raised their price target on Intuitive Surgical from $470.00 to $550.00 and gave the stock an “in-line” rating in a report on Tuesday, July 8th. Thirteen research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $595.95.

Insider Transactions at Intuitive Surgical

In other news, insider Gary S. Guthart sold 29,360 shares of the firm’s stock in a transaction dated Friday, August 29th. The stock was sold at an average price of $472.49, for a total value of $13,872,306.40. Following the completion of the transaction, the insider directly owned 19,827 shares in the company, valued at $9,368,059.23. This trade represents a 59.69% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, EVP Myriam Curet sold 4,500 shares of the firm’s stock in a transaction dated Friday, July 25th. The stock was sold at an average price of $492.48, for a total value of $2,216,160.00. Following the completion of the transaction, the executive vice president owned 353 shares of the company’s stock, valued at approximately $173,845.44. The trade was a 92.73% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 45,224 shares of company stock worth $21,716,492 over the last three months. 0.70% of the stock is currently owned by insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.